Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 5, 2024
- Accession no.
- 0001415889-24-022972
- Filed
- Sep 5, 2024
- Trade date
- Sep 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $30.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | SSaleDisposed | −410 | $6.71 | −$2,751.1 | 299,609 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −724 | $6.69 | −$4,843.56 | 298,885 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −1,842 | $6.69 | −$12,322.98 | 297,043 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −1,610 | $6.71 | −$10,803.1 | 295,433 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.